New Advances in the Treatment of Schizophrenia Results from Short- and Long-Term Clinical Trials of Iloperidone: Supplement
Cutler, Andrew J. MD*†; Kalali, Amir H. MD‡§; Weiden, Peter J. MD∥; Hamilton, Jennifer MS¶; Wolfgang, Curt D. PhD¶
Author Information
*University of Florida, Gainesville, FL; †Florida Clinical Research Center, LLC, Maitland, FL; ‡University of California San Diego, CA; §Quintiles CNS Therapeutics, San Diego, CA; ∥Center for Cognitive Medicine, University of Illinois Medical Center, Chicago, IL; and ¶Vanda Pharmaceuticals Inc, Rockville, MD.
Received December 14, 2007; accepted after revision January 19, 2008.
This study was supported by Vanda Pharmaceuticals Inc. This clinical study complied with the current laws of the countries in which they were performed.
Address correspondence and reprint request to Andrew J. Cutler, MD, Florida Clinical Research Center, 2300 Maitland Center Parkway, Suite 230, Maitland, FL 32751. E-mail: [email protected].
doi: 10.1097/JCP.0b013e318169d4ce